Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB for Sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where LENVATINIB was used for Sarcoma.

Most Reported Side Effects for LENVATINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 4,262 12.6% 321 2,714
Hypertension 4,152 12.3% 405 2,522
Fatigue 3,603 10.7% 208 2,023
Decreased appetite 3,257 9.7% 363 2,209
Malignant neoplasm progression 2,929 8.7% 1,549 1,298
Nausea 2,492 7.4% 160 1,637
Blood pressure increased 2,228 6.6% 104 1,411
Vomiting 1,962 5.8% 122 1,458
Asthenia 1,643 4.9% 122 1,180
Malaise 1,602 4.7% 241 989
Weight decreased 1,529 4.5% 106 901
Dehydration 1,526 4.5% 97 1,375
Pyrexia 1,438 4.3% 134 1,149
Hypothyroidism 1,375 4.1% 165 698
Headache 1,268 3.8% 50 810

Other Indications for LENVATINIB

Endometrial cancer (6,770) Hepatocellular carcinoma (5,384) Renal cell carcinoma (3,849) Renal cancer (2,862) Thyroid cancer (2,668) Uterine cancer (2,233) Hepatic cancer (1,017) Clear cell renal cell carcinoma (935) Product used for unknown indication (916) Papillary thyroid cancer (501)

Other Drugs Used for Sarcoma

DOXORUBICIN (409) PAZOPANIB (296) IFOSFAMIDE (280) EPIRUBICIN (132) NIVOLUMAB (124) VINCRISTINE (105) CYCLOPHOSPHAMIDE (79) ETOPOSIDE (75) TRABECTEDIN (75) TRONOXAL INYECTABLE (74)

Related Pages

LENVATINIB Full Profile All Sarcoma Drugs LENVATINIB Demographics LENVATINIB Timeline